Read More Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Plains GP Holdings, Raises Price Target to $14 By Benzinga Newsdesk Today, 5:02 AM Wells Fargo analyst Michael Blum maintains Plains GP Holdings (NASDAQ:PAGP) with a Overweight and raises the price target from $12 to $14. PAGP
Read More Analyst Ratings News Price Target HC Wainwright & Co. Maintains Buy on IVERIC bio, Raises Price Target to $26 By Benzinga Newsdesk Today, 5:02 AM HC Wainwright & Co. maintains IVERIC bio (NASDAQ:ISEE) with a Buy and raises the price target from $20 to $26. ISEE
Read More Dividends Earnings News Here’s How Much $100 Invested In Enbridge 20 Years Ago Would Be Worth Today By Benzinga Insights Today, 5:02 AM Enbridge (NYSE:ENB) has outperformed the market over the past 20 years by 2.27% on an annualized basis. ENB
Read More FDA News Establishment Labs Highlights Publication Of Breast Implant Surface Research In Nature Biomedical Engineering By Benzinga Newsdesk Today, 5:02 AM Professor Robert Langer and a team of MIT scientists demonstrated that an optimal breast implant surface architecture leads to significantly lower levels of inflammatory foreign body response and to healthier tissue ESTA